Background and Aims: Seed amplification assays (SAAs) have shown promising results in detecting misfolded TDP‐43 in cerebrospinal fluid (CSF) of patients with genetic FTD with TDP‐43 pathology. Here, TARDBP is linked to frontotemporal dementia.